J&J | JNJ - Operating Expenses


J&J reported $17.83B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
AbbVie USD 10.27B 1000K Jun/2026
Abbott USD 10.46B 1.15B Jun/2026
Amgen USD 11.69B 6.9B Jun/2026
AstraZeneca USD 12.22B 4.04B Jun/2026
Baxter International USD 2.68B 3.36B Jun/2026
Bayer EUR 10.04B 168M Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Biogen USD 2.98B 1.02B Jun/2026
Boston Scientific USD 4.2B 49M Jun/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
CONMED USD 307.08M 15.45M Jun/2026
Cooper Companies USD 1.11B 301.2M Mar/2026
Dexcom USD 990.1M 53.5M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
Eli Lilly USD 10.52B 496M Jun/2026
Gilead Sciences USD 3.95B 19.57B Jun/2026
GlaxoSmithKline GBP 5.8B 468M Jun/2026
Globus Medical USD 835.58M 239.73M Jun/2026
Insulet USD 672M 32.3M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
Intuitive Surgical USD 1.91B 3.6M Jun/2026
J&J USD 17.83B 388M Jun/2026
Medtronic USD 7.72B 436M Mar/2026
Merck USD 15.77B 2.4B Jun/2026
Merit Medical Systems USD 358.44M 20.72M Jun/2026
Novartis USD 10.2B 912M Jun/2026
Pfizer USD 85.19B 4.91B Jun/2026
Regeneron Pharmaceuticals USD 31.71B 287.8M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sanofi EUR 9.92B 607M Jun/2026
Stryker USD 4.8B 118M Jun/2026
Tandem Diabetes Care USD 268.35M 3.7M Jun/2026
Teva Pharmaceutical Industries USD 3.92B 691M Jun/2026
Vertex Pharmaceuticals USD 2.07B 217.1M Jun/2026
Zimmer Biomet Holdings USD 1.83B 140.7M Jun/2026
Zoetis USD 3.15B 85M Jun/2026